Bafna Pharmaceuticals receives renewal certificate from MHRA

10 Jun 2015 Evaluate

Bafna Pharmaceuticals has received the renewal certificate from MHRA, London. The company had earlier on March 02, 2015, successfully cleared the renewal of audit process as per the guidelines issued by the Medicine and Healthcare Product Agency (MHRA- UK) for European Union GMP.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.



Bafna Pharma Share Price

146.05 -2.95 (-1.98%)
16-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.30
Dr. Reddys Lab 1276.40
Cipla 1506.35
Zydus Lifesciences 920.50
Lupin 2088.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×